A new clinical trial is exploring a different strategy for tackling one of obesity treatment’s biggest challenges: keeping weight off after initial success.

Add Yahoo as a preferred source to see more of our stories on Google. But recent findings suggest keeping the weight off after stopping the so-called miracle drugs can be extremely challenging.

Meeting your weight loss goals on GLP-1s is great progress. Learn how to maintain your new weight and how weight loss ...

A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

That’s the question Kourtney Kardashian-Barker’s women’s supplement brand was aiming to answer with its latest launch. The ...

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, ...

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...

In ATTAIN-MAINTAIN, orforglipron achieved the primary and all key secondary endpoints for weight maintenance vs. placebo at 52 weeks following weight loss on Wegovy or Zepbound Participants who ...

Maggie Linton has never been fond of injections, so when she heard that Eli Lilly was working on a GLP-1 pill, she was eager ...

Weight-loss drugs such as Mounjaro have been praised for triggering dramatic weight loss for about 1.6 million people in the UK. But recent findings suggest keeping the weight off after stopping the ...